Symbol="MNPR"
AssetType="Common Stock"
Name="Monopar Therapeutics Inc"
Description="Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, is dedicated to developing proprietary therapies to improve clinical outcomes for cancer patients in the United States. The company is headquartered in Wilmette, Illinois."
CIK="1645469"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1000 SKOKIE BLVD SUITE 350, WILMETTE, IL, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="9903400"
EBITDA="None"
PERatio="None"
PEGRatio="None"
BookValue="0.676"
DividendPerShare="0"
DividendYield="0"
EPS="-0.78"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.443"
ReturnOnEquityTTM="-0.81"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.78"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="8.1"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="2.723"
EVToRevenue="-"
EVToEBITDA="-1.918"
Beta="0.924"
num_52WeekHigh="4.88"
num_52WeekLow="0.633"
num_50DayMovingAverage="0.838"
num_200DayMovingAverage="1.978"
SharesOutstanding="13222100"
DividendDate="None"
ExDividendDate="None"
symbol="MNPR"
open="0.75"
high="0.75"
low="0.66"
price="0.71"
volume="38138.00"
latest_trading_day="2023-08-11"
previous_close="0.75"
change="-0.04"
change_percent="-5.2069%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="90"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="10"
Volume_recent_avg="337439"
Change_recent_avg="-0.01"
Delta_recent_avg="0.09"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-1.2"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_negative_30"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="10"
Aroon_momentum_negative="90"
image_negative_thumbnail_id_1="101"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0075.jpeg"
image_negative_thumbnail_id_2="495"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0110.jpeg"
image_neutral_thumbnail_id_1="584"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0015.jpeg"
image_neutral_thumbnail_id_2="432"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Neutral_Landscape_0019.jpeg"
image_positive_thumbnail_id_1="605"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0103.jpeg"
image_positive_thumbnail_id_2="967"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0129.jpeg"
image_professor_thumbnail_id_1="1185"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
image_professor_thumbnail_id_2="1202"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
